{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:11:41Z","timestamp":1760055101982,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.medmal.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T17:00:34Z","timestamp":1350320434000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccinal issues between Belgian and French travelers"],"prefix":"10.1016","volume":"42","author":[{"given":"S.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Huleux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Choisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ajana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2012.08.002_bib0005","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9, Bruxelles. Guide de vaccination. 2009 - n\u030a8586."},{"key":"10.1016\/j.medmal.2012.08.002_bib0010","first-page":"489","article-title":"L\u2019\u00e9radication de la poliomy\u00e9lite\u00a0: o\u00f9 en est-on en 2010\u00a0?","volume":"48","author":"Antona","year":"2010","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.medmal.2012.08.002_bib0015","first-page":"374","article-title":"Measles outbreaks and progress toward measles preelimination - African region, 2009\u20132010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"2011","series-title":"\u00c9pid\u00e9mie de rougeole en France. Actualisation des donn\u00e9es au 5 octobre 2011","author":"Institut National de Veille Sanitaire","key":"10.1016\/j.medmal.2012.08.002_bib0020"},{"key":"10.1016\/j.medmal.2012.08.002_bib0025","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1001\/jama.1991.03470190072032","article-title":"The susceptibilityof young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits","volume":"266","author":"Kelley","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2012.08.002_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(90)90244-G","article-title":"Polio immunity to killed vaccine: an 18-year follow-up","volume":"8","author":"Bottiger","year":"1990","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.medmal.2012.08.002_bib0035","first-page":"104","article-title":"Progress in interrupting wild poliovirus circulation in countries with re-established transmission: Africa, 2009\u20132010","volume":"86","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"1993","series-title":"Immunological basis for immunization series, Module 6: Poliomyelitis","author":"World Health Organization","key":"10.1016\/j.medmal.2012.08.002_bib0040"},{"key":"10.1016\/j.medmal.2012.08.002_bib0045","first-page":"223","article-title":"Response of children to a single dose of oral or inactivated polio vaccine","volume":"47","author":"Magrath","year":"1981","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.medmal.2012.08.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","article-title":"The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccines for ten years","volume":"12","author":"Nishio","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.medmal.2012.08.002_bib0055","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/iai.63.4.1336-1339.1995","article-title":"Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults","volume":"63","author":"Cryz","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2012.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/iai.64.4.1454-1457.1996","article-title":"Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines","volume":"64","author":"Kollaritsch","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.medmal.2012.08.002_bib0065","first-page":"522","article-title":"Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated cholera CVD103-HgR and typhoid ty21a vaccines","volume":"179","author":"Tsai","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2012.08.002_bib0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/513984","article-title":"Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine","volume":"175","author":"Kollaritsch","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2012.08.002_bib0075","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/342908","article-title":"Efficacy of atovaquone\/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines","volume":"35","author":"Faucher","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2012.08.002_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/esm.00.00.00201-en","article-title":"Immunisation schedules in the countries of the European Union","volume":"1","author":"Guerin","year":"1995","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2012.08.002_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(03)00519-X","article-title":"Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts","volume":"3","author":"Schmitt","year":"2003","journal-title":"Lancet Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12002041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12002041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:11:13Z","timestamp":1759972273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X12002041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0399077X12002041"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2012.08.002","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinal issues between Belgian and French travelers","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2012.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}